2007 Annual Meeting | Contemporary Clincial Issues Plenary
| 09:00 AM - 12:00 PM |
Abstract Presenter: Genetic Correlates of Brain Aging on MRI and Cognitive Test Measures: Genome-Wide Association Analyses in the Framingham Heart Study
Sudha Seshadri, MD, FAAN |
|
| 09:00 AM - 12:00 PM |
Discussant: Genetic Correlates of Brain Aging on MRI and Cognitive Test Measures: Genome-Wide Association Analyses in the Framingham Heart Study
John A. Hardy, PhD |
|
| 09:00 AM - 12:00 PM |
Abstract Presenter: The Neurochemical Aftermath of Amateur Boxing
Max Albert Hietala, MD |
|
| 09:00 AM - 12:00 PM |
Discussant: The Neurochemical Aftermath of Amateur Boxing
James P. Kelly, MD, FAAN |
|
| 09:00 AM - 12:00 PM |
Abstract Presenter: Secondary Analysis of Hemorrhagic Stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study
Larry B. Goldstein, MD, FAHA, FAAN |
|
| 09:00 AM - 12:00 PM |
Discussant: Secondary Analysis of Hemorrhagic Stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study
Bruce I. Ovbiagele, MD, MSc, FAAN |
|
| 09:00 AM - 12:00 PM |
Sodium Channels as Targets for Pain Management: Lessons from Inherited Pain Syndromes
Geoffrey Woods |
|
| 09:00 AM - 12:00 PM |
Idebenone Treatment for Friedrich's Ataxia
Kenneth H. Fischbeck, MD, FAAN |
|
| 09:00 AM - 12:00 PM |
How Should we Treat the Patient with Persistent Painful Lumbosacral Radiculopathy?
J. D. Bartleson, MD, FAAN |
| J. D. Bartleson, MD, FAAN | Dr. Bartleson has nothing to disclose. |
| Kenneth H. Fischbeck, MD, FAAN | Dr. Fischbeck has received research support from NINDS/NIH. Dr. Fischbeck has received intellectual property interests from a discovery or technology relating to health care. Dr. Fischbeck has a non-compensated relationship as a Scientific Review Board member with Kennedy's Disease Association that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Council member with Association Francaise contre les Myopathies that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Independent Review Committee member with Target ALS that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Board member, Musculoskeletal Diseases with Novartis that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Senior Clinical Consultant with n-Lorem Foundation that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Committee member with Stanford GNE myopathy program that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Board member with Hereditary Disease Foundation that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Board member with Packard Center for ALS Research that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Board member with Huntington's Disease Society of America that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a TACT review panel member with TREAT-NMD that is relevant to AAN interests or activities. |
| Larry B. Goldstein, MD, FAHA, FAAN | The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from Janssen. Dr. Goldstein has received publishing royalties from a publication relating to health care. |
| James P. Kelly, MD, FAAN | No disclosure on file |
| Sudha Seshadri, MD, FAAN | Dr. Seshadri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Seshadri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Seshadri has received research support from NIH. The institution of Dr. Seshadri has received research support from Alzheimer Association. |
| John A. Hardy, PhD | No disclosure on file |
| Bruce I. Ovbiagele, MD, MSc, FAAN | Dr. Ovbiagele has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Stroke Association. Dr. Ovbiagele has received research support from National Institutes of Health. Dr. Ovbiagele has a non-compensated relationship as a President with Society for Equity Neuroscience that is relevant to AAN interests or activities. Dr. Ovbiagele has a non-compensated relationship as a Board Member with World Stroke Organization that is relevant to AAN interests or activities. |
| Max Albert Hietala, MD | No disclosure on file |
| Geoffrey Woods | No disclosure on file |